SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its second quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, August 12, 2021 at 4:30PM EDT.
To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 8694398. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
Investor Relations Contact
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
Media Contact
Glenn Silver
Glenn.Silver@Finnpartners.com
(646) 871-8485
SOURCE: Achieve Life Sciences, Inc.
View source version on accesswire.com:
https://www.accesswire.com/655760/Achieve-Life-Sciences-to-Announce-Second-Quarter-2021-Financial-Results-and-Host-Conference-Call-and-Webcast-on-August-12-2021
DENVER, June 12, 2024 /PRNewswire/ -- Momcozy, a leading provider of maternity products and nursing…
NEW YORK, June 12, 2024 /PRNewswire/ -- The global X-ray equipment market size is estimated…
SCHAFFHAUSEN, Switzerland, June 12, 2024 /PRNewswire/ -- The shareholders of TE Connectivity Ltd. (NYSE: TEL) approved…
MARIETTA, Ga., June 12, 2024 /PRNewswire/ -- BRIJ Medical is proud to announce that it…
Donald Trump leads over President Joe Biden among older voters; Senate race is neck-and-neck between…
SUSSEX, Wis., June 12, 2024 /PRNewswire/ -- Quad/Graphics, Inc. (NYSE: QUAD), a global marketing experience…